Abstract

The rare and heterogeneous kidney disorder C3 glomerulopathy (C3G) is characterized by dysregulation of the alternative pathway (AP) of the complement system. C3G is often associated with autoantibodies stabilizing the AP C3 convertase named C3 nephritic factors (C3NeF). The role of classical pathway (CP) convertase stabilization in C3G and related diseases such as immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) remains largely unknown. Here, we investigated the CP convertase activity in patients with C3G and IC-MPGN. Using a refined two-step hemolytic assay, we measured the stability of CP convertases directly in the serum of 52 patients and 17 healthy controls. In four patients, CP convertase activity was prolonged compared to healthy controls, i.e. the enzymatic complex was stabilized. In three patients (2 C3G, 1 IC-MPGN) the convertase stabilization was caused by immunoglobulins, indicating the presence of autoantibodies named C4 nephritic factors (C4NeFs). Importantly, the assay also enabled detection of non-immunoglobulin-mediated stabilization of the CP convertase in one patient with C3G. Prolonged CP convertase activity coincided with C3NeF activity in all patients and for up to 70 months of observation. Crucially, experiments with C3-depleted serum showed that C4NeFs stabilized the CP C3 convertase (C4bC2a), that does not contain C3NeF epitopes. All patients with prolonged CP convertase activity showed clear signs of complement activation, i.e. lowered C3 and C5 levels and elevated levels of C3d, C3bc, C3bBbP, and C5b-9. In conclusion, this work provides new insights into the diverse aspects and (non-)immunoglobulin nature of factors causing CP convertase overactivity in C3G/IC-MPGN.

Highlights

  • C3 glomerulopathy (C3G) is an umbrella term for kidney diseases characterized by glomerular inflammation and accumulation of breakdown fragments of complement component C3 in the glomeruli [1, 2]

  • We investigated whether classical pathway (CP) convertase overactivity occurred in our patient cohort consisting of 45 patients with C3G and 7 patients with IC-membranoproliferative glomerulonephritis (MPGN)

  • Maximal CP convertase activity was reached after 0.5-2.5 min, followed by a sharp decrease in hemolysis in all samples at 5 min of incubation and onwards

Read more

Summary

Introduction

C3 glomerulopathy (C3G) is an umbrella term for kidney diseases characterized by glomerular inflammation and accumulation of breakdown fragments of complement component C3 in the glomeruli [1, 2]. The diagnosis requires a kidney biopsy showing C3 staining that is dominant over other immune reactants by immunofluorescence microscopy. The two major subgroups within the classification of C3G are dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD is distinguished from C3GN by characteristic, highly electron-dense, intramembranous sausage-shaped deposits in electron microscopy [1, 2]. Current therapy encompasses antihypertensive agents and immunosuppressive drugs such as prednisone and mycophenolate mofetil. Despite this treatment, many patients progress to kidney failure within ten years [2, 3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call